| Literature DB >> 32171302 |
Abstract
BACKGROUND: Communities' engagement in priority-setting is a key means for setting research topics and questions of relevance and benefit to them. However, without attention to dynamics of power and diversity, their engagement can be tokenistic. So far, there remains limited ethical guidance on how to share power with communities, particularly those considered disadvantaged and marginalised, in global health research priority-setting. This paper generates a comprehensive, empirically-based "ethical toolkit" to provide such guidance, further strengthening a previously proposed checklist version of the toolkit. The toolkit places community engagement and power-sharing at the heart of priority-setting for global health research projects.Entities:
Keywords: Engagement; Ethics; Global health; Justice; Participation; Power; Priority-setting; Research
Mesh:
Year: 2020 PMID: 32171302 PMCID: PMC7071780 DOI: 10.1186/s12910-020-0462-y
Source DB: PubMed Journal: BMC Med Ethics ISSN: 1472-6939 Impact factor: 2.652
Fig. 1Components of engagement
Comparison of sites of power described by interviewees relative to those described in the literature
| Component of engagement | Sites of power-sharing identified by | Sites of power-sharing identified by | Sites of power-sharing identified in |
|---|---|---|---|
The rules under which health research priority-setting is undertaken. They specify who can and cannot be present, who can speak and when, how different individuals’ views are used, and how a decision or closure is reached. | Who takes the lead on key aspects of research priority-setting: planning, implementing, and ensuring outputs are fed back and used. | The reason(s) for engaging community members in global health research priority-setting. Can be instrumental (i.e. as a means to another goal) and/or transformative (i.e. to generate empowerment). | |
Whether there is openness and honesty about any constraints surrounding the priority-setting process, the ground rules for priority-setting, and what happens after priority-setting. | What issues can be brought into the priority-setting space and what issues are not allowed; What information is presented or shared with participants at the start of the priority-setting process. | Whether community participants span a wide spectrum of relevant roles and demographics. Relevant roles could be: patients, families and carers, providers, purchasers, payers, policymakers, and product makers. Ensuring the presence of marginalised groups is also key to achieving range. | |
The physical setting in which health research priority-setting is undertaken. | When community members are allowed to participate in the health research priority-setting process. | ||
Whether interpersonal and cultural respect are shown for community participants. | The mode(s) of participation assumed by community participants during health research priority-setting. | ||
Features of a community or a community organisation partner that can be drawn upon to support the representation and voices of its members, esp. those considered marginalised, during health research priority-setting. | Whether community members are represented during health research priority-setting. Encompasses considerations related to the channel of representation and the genuineness of representation. | ||
Whether community participants are able to speak and be heard during health research priority-setting. Encompasses considerations related to facilitation, documentation, and synthesis of global health research priorities. | |||
The numbers of participants representing powerful versus less powerful community members. | |||
Responsibilities of researchers, research institutions, and community members after priority-setting. |
Generating ethical considerations for the revised toolkit in relation to sites of power identified by both conceptual and empirical analysis
| Site of power | Initial toolkit version of ethical consideration | Revised toolkit version of ethical consideration |
|---|---|---|
| Representation | 1. Particular citizens to represent selected roles and groups: a. Are they likely to authentically represent their role or group? b. Do they represent the axes of difference selected to be included in priority-setting? c. Do they see themselves as representing these axes of difference? d. Who selects them? • Members of their group or community • Local leaders/authorities • Organisers of the priority-setting process • Experts (researchers) • Other ____________________________ 2. Particular organisations to represent selected roles and groups: a. Do organisations exist that authentically represent the selected roles and disadvantaged groups? b. Do their memberships encompass the selected axes of difference? c. Do power disparities exist between selected organisations? d. Who selects individuals to represent organisations in priority-setting? • Their members • Their leaders • Organisers of the priority-setting process • Experts (researchers) • Other ____________________________ | Which organisations or individuals will represent the selected roles and groups? Points to consider: 1. Does it make sense to ask community leaders, community members, or key informants to select individuals or organisations to represent the identified roles and groups? If yes, consider giving them some criteria that you’re hoping representatives will meet in order to avoid selection biases. 2. Do you have evidence that these organisations’ memberships reflect the group or roles’ diversity and are regularly consulted about their needs and priorities? 3. Where individuals will represent a role or group, do they collectively reflect its diversity and share lived experience with those they are representing? 4. Do any of the selected representatives have substantial financial conflicts of interest that you think will bias their identification of research priorities? |
| Framing | Is priority-setting framed in a non-neutral way that excludes some of their key health needs? | Will you make it clear to participants that any or most health research topics can be raised during priority-setting? OR Will it been made clear to participants that |
| Having voice | 1. In what ways will power suppress citizens’ agency in deliberations during priority-setting? 2. Will strategies be implemented to counteract the impact of these power dynamics on citizens’ agency in the deliberative process? 3. Will research priorities and questions be internally synthesised? By whom? • Citizens, including less powerful citizens • Researchers and citizens, including members of disadvantaged groups and less powerful citizens • Researchers and citizens • Researchers 4. If they’ll be externally synthesised, what is the justification? 5. Has local knowledge from citizens along axes of powerlessness and disadvantaged groups been used? If yes, which ones and why? If not, why not? | 1a. Will you have a locally-based person facilitate focus groups or deliberations during priority-setting? If not, what are your reasons? 1b. How will the facilitation method/approach help equalise power dynamics between community members? 2a. Will you have a locally-based person document the priority-setting process? If not, what are your reasons? 2b. How will community members be given an opportunity to review the documentation of the priority-setting process? 3. Will you give the voices of community members, especially those considered disadvantaged or marginalised, equal or greater weight than other voices when setting research priorities? If not, what are your reasons? |
| Leadership | 1. Will the engagement process be initiated by: a. Local researchers and citizens, or citizens alone b. Foreign researchers, local researchers, and citizens c. Foreign researchers and local researchers d. Foreign researchers 2. If solely foreign researchers, what is the justification? | Who will initiate and lead engagement with community members during health research priority-setting? |
| Mass | 1. Does the number of participants representing those who lack power over health decision-making balance or exceed the number of participants representing those who typically have such power? | 1. Will the number of representatives of lower status community roles be equal to or exceed the number of representatives of higher status community roles at each stage of the priority-setting process? If not, what are your reasons? 2. Will a sufficient number of representatives of lower status roles be engaged in each stage of the priority-setting process? If not, what are your reasons? |
| Level of participation | 1. Will decision-making be limited to (foreign) researchers, i.e. “experts”? 2. At what level will each group participate? a. Lay control b. Decision-making c. Consultation | 1. Will you involve community members as collaborators (decision-makers) in priority-setting? If yes, in what stages of the priority-setting process? If not, what are your reasons? 2. Is it fair to bring these community members into the same decision-making space? |
| Stage of participation | 1. Will those who typically have power over health decision-making—(foreign) researchers, policymakers—enter the process earlier than those who do not? 2. When will each group be included? a. Planning the process, b. Research topic solicitation and prioritization, c. Formulating the research question, and/or d. Designing the intervention | 1. Will you involve community partners and members from the start of the priority-setting process? If not, what are your reasons? 2. Will less influential and lower status community roles be involve later and in fewer stages of the priority-setting process than higher status and more influential roles? |